GLYC Old Top Management
| GLYCDelisted Stock | USD 0.16 0.01 5.88% |
GLYC Old employs about 4 people. The company is managed by 11 executives with a total tenure of roughly 51 years, averaging almost 4.0 years of service per executive, having 0.36 employees per reported executive. Evaluation of GLYC Old's management performance can provide insight into the firm performance.
| Rachel King CEO President CEO, Founder, Director |
| Armand Girard President Senior Vice President Strategy and Corporate Development |
GLYC |
GLYC Old Management Team Effectiveness
The company has return on total asset (ROA) of (0.7399) % which means that it has lost $0.7399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8266) %, meaning that it created substantial loss on money invested by shareholders. GLYC Old's management efficiency ratios could be used to measure how well GLYC Old manages its routine affairs as well as how well it operates its assets and liabilities.GLYC Old has a total of 64.53 Million outstanding shares. 30% of GLYC Old outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as GLYC Old in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of GLYC Old, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
GLYC Old Workforce Comparison
GLYC Old is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,629. GLYC Old adds roughly 4.0 in number of employees claiming only tiny portion of equities under Health Care industry.
GLYC Old Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GLYC Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on GLYC Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, GLYC Old insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
GLYC Old Notable Stakeholders
A GLYC Old stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as GLYC Old often face trade-offs trying to please all of them. GLYC Old's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting GLYC Old's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Rachel King | President CEO, Founder, Director | Profile | |
| Harout Semerjian | President CEO | Profile | |
| Armand Girard | Senior Vice President Strategy and Corporate Development | Profile | |
| Brian Hahn | CFO and Principal Accounting Officer | Profile | |
| John Magnani | Chief Scientific Officer, VP and Director | Profile | |
| Edwin MD | Senior Officer | Profile | |
| Chinmaya Rath | Senior Officer | Profile | |
| Stephanie CPA | Vice Accounting | Profile | |
| Bruce Johnson | Senior Officer | Profile | |
| Shantha Tyavanagimatt | Senior Operations | Profile | |
| Christian DinneenLong | General Secretary | Profile |
About GLYC Old Management Performance
The success or failure of an entity such as GLYC Old often depends on how effective the management is. GLYC Old management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of GLYC management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the GLYC management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland. Glycomimetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
Please note, the presentation of GLYC Old's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GLYC Old's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of GLYC Old's management manipulating its earnings.
GLYC Old Workforce Analysis
Traditionally, organizations such as GLYC Old use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare GLYC Old within its industry.GLYC Old Manpower Efficiency
Return on GLYC Old Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 9.5M | |
| Net Loss Per Executive | 3.4M | |
| Working Capital Per Employee | 1.3M | |
| Working Capital Per Executive | 483.1K |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in GLYC Stock
If you are still planning to invest in GLYC Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GLYC Old's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |